Some GLP-1 receptor agonists (including liraglutide, semaglutide, and dulaglutide) have demonstrated cardiovascular outcome benefits in people with type 2 diabetes and established cardiovascular disease or high cardiovascular risk
J Clin Investig 110(5):597603
A- If vitamin B12 absorption is impaired or if there is a deficiency state where rapid replenishment is desired, injection therapy is superior
Studies show that when people quit GLP-1 medications after a year, they tend to regain up to two-thirds of the weight they lost
For researchers building comprehensive peptide protocols, GHK-Cus complementary profile, including blends with BPC-157/TB-500, growth hormone secretagogues, and neuropeptides, positions it as a foundational element rather than a peripheral add-on